This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Strömer, H. Articles by Neubauer, S. Search for Related Content PubMed PubMed Citation Articles by Strömer, H. Articles by Neubauer, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL Medline Plus Health Information Cardiomyopathy Related Collections Cardiovascular Pharmacology Ischemic biology - basic studies

(Circulation. 2000;101:2749.)
© 2000 American Heart Association, Inc.

Basic Science Reports

Na⁺/H⁺ Exchange Inhibition With HOE642 Improves Postischemic Recovery due to Attenuation of Ca²⁺ Overload and Prolonged Acidosis on Reperfusion

Hinrik Strömer, MD; Mark C. H. de Groot, PhD; Michael Horn, PhD; Christian Faul; Andrea Leupold; James P. Morgan, MD, PhD; Wolfgang Scholz, MD; Stefan Neubauer, MD

From the Medizinische Universitätsklinik (H.S., M.C.H.d.G., M.H., C.F., A.L., S.N.), Würzburg, Germany; Harvard-Thorndike Laboratory (J.P.M.), Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass; and the HMR Deutschland GmbH (W.S.), Frankfurt/Main, Germany.

Correspondence to Hinrik Strömer, MD, Medizinische Universitätsklinik, Josef-Schneider-Straße 2, 97080 Würzburg, Germany. E-mail stromer{at}mail.uni-wuerzburg.de

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background—Na⁺/H⁺ exchange inhibition with HOE642 (cariporide) improves postischemic recovery of cardiac function, but the mechanisms of action remain speculative. Because Na⁺/H⁺ exchange is activated on reperfusion, it was hypothesized that its inhibition delays realkalinization and decreases intracellular Na⁺ and, via Na⁺/Ca²⁺ exchange, Ca²⁺ overload. Attenuated Ca²⁺ overload and prolonged acidosis are known to be cardioprotective.

Methods and Results—Left ventricular developed and end-diastolic pressures were measured in isolated buffer-perfused rat hearts subjected to 30 minutes of no-flow ischemia and 30 minutes of reperfusion (37°C) with or without 1 µmol/L HOE642 added to the perfusate 15 minutes before ischemia. Intracellular Ca²⁺ concentration ([Ca²⁺]_i) and pH_i were measured with aequorin (n=10 per group) and ³¹P NMR spectroscopy (n=6 per group), respectively. HOE642 did not affect preischemic mechanical function, [Ca²⁺]_i, or pH_i. Mechanical recovery after 30 minutes of reperfusion was substantially improved with HOE642: left ventricular developed pressure (in percent of preischemic values) was 92±3 versus 49±7 and left ventricular end-diastolic pressure was 16±3 versus 46±5 mm Hg (P<0.05 for HOE642-treated versus untreated hearts). End-ischemic [Ca²⁺]_i was significantly lower in HOE642-treated than in untreated hearts (1.04±0.06 versus 1.84±0.02 µmol/L, P<0.05). Maximal intracellular Ca²⁺ overload during the first 60 seconds of reperfusion was attenuated with HOE642 compared with untreated hearts: 2.0±0.3 versus 3.2±0.3 µmol/L (P<0.05). pH_i was not different at end ischemia (5.9±0.05). Realkalinization was similar in the first 90 seconds of reperfusion and significantly delayed in the next 3 minutes (eg, 6.8±0.07 in HOE642-treated hearts compared with 7.2±0.07 in untreated hearts; P<0.05).

Conclusions—HOE642 improves postischemic recovery by reducing Ca²⁺ overload during ischemia and early reperfusion and by prolonging postischemic acidosis.

Key Words: stunning, myocardial • myocardium • calcium • reperfusion

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Intracellular Ca²⁺ overload on reperfusion after prolonged ischemia is an important pathophysiological factor that contributes to reduced postischemic recovery of mechanical function.^{1 2} It has been demonstrated that the Na⁺/Ca²⁺ exchanger is largely responsible for the excessive Ca²⁺ influx during ischemia and reperfusion, which occurs secondary to intracellular Na⁺ overload.^{3 4 5} It has been hypothesized that during early reperfusion, Ca²⁺ overload is aggravated by the activation of the Na⁺/H⁺ exchanger, with protons extruded in exchange for Na⁺ on realkalinization.

Pretreatment with Na⁺/H⁺ exchange has been shown to provide substantial improvement of postischemic recovery in vivo and in isolated muscle preparations: amiloride, the classic Na⁺/H⁺ exchange inhibitor, improved postischemic recovery and attenuated intracellular Ca²⁺ overload.^{5 6 7} However, its effect on Na⁺/H⁺ exchange is rather nonspecific, because it also inhibits Na⁺/Ca²⁺ exchange,⁶ the T-type Ca²⁺- and the tetrodotoxin-sensitive Na⁺ channels.⁸ The first specific Na⁺/H⁺ exchange inhibitor, HOE694, demonstrated cardioprotective effects in ischemia-reperfusion injury.^{8 9} Efforts to further improve potency and specificity led to the development of HOE642 (cariporide), a selective Na⁺/H⁺ exchanger subtype I (the prevailing cardiovascular subtype) inhibitor. In a variety of ischemia models, HOE642 revealed a similar cardioprotective effect.¹⁰ The preliminary results of a large multicenter trial (Guardian Trial) revealed beneficial effects of the drug in patients with acute coronary syndromes.¹¹ However, results of studies on the precise mechanisms of action of HOE642 in ischemia-reperfusion have not been reported. It has been hypothesized that the cardioprotective effect of Na⁺/H⁺ exchange inhibition is mediated by delayed realkalinization on reperfusion with consequent attenuation of Na⁺ overload and, thus, intracellular Ca²⁺ overload.⁴ Both preservation of acidosis and reduced Ca²⁺ overload were shown to be cardioprotective.^{3 12} To test this hypothesis for HOE642 during ischemia-reperfusion, measurements of intracellular Ca²⁺ concentration ([Ca²⁺]_i) and pH_i with high temporal resolution are required. In the present study, we used aequorin bioluminescence and ³¹P NMR spectroscopy techniques to assess [Ca²⁺]_i and pH_i, respectively, in an isolated heart model.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Isolated Heart
Studies were conducted according to the guidelines of the American Physiological Society Principles for Research Involving Animals and Human Beings. Isolated hearts were dissected and perfused as described previously.¹³ Briefly, male Wistar rats aged 8 to 10 weeks with a body weight of 300 to 330 g and a heart weight of 1.2 to 1.3 g were anesthetized with intraperitoneal pentobarbital, and the hearts were retrogradely perfused within 30 seconds after thoracotomy with an oxygenated (95% O₂/5% CO₂, pH 7.4, at 37°C) Krebs-Henseleit solution containing (in mmol/L) NaCl 118, KCl 4.7, NaHCO₃ 23, MgCl₂ 1.2, CaCl₂ 1.5, and dextrose 5.2. Left ventricular (LV) isovolumic pressure was recorded with an intraventricular latex balloon attached to a Statham P 23 XL transducer. The hearts were paced at 5 Hz with rectangular wave pulses (5 ms, 5 to 10 V, 20% above threshold). Cardiac temperature was monitored with a temperature probe inserted into the right ventricle. Care was taken to ensure isothermic conditions (37.0±0.3°C) during the ischemia protocol with a temperature-regulated organ bath (Gary Harrer). Coronary flow was set at 12 mL · min^-1 · g heart wt^-1, yielding a coronary perfusion pressure of 60 to 70 mm Hg. This flow rate was kept constant except during no-flow ischemia.

LV Pressure Recordings
LV pressure tracings were digitized with a 12-bit AD converter (sampling rate 1 kHz) and stored on magnetic disk. LV developed and end-diastolic pressures (LVDP and LVEDP, respectively), time to peak contraction (TP), time constant of exponential pressure decay (tau; with use of the variable asymptote method¹⁴ ), and maximum and minimum values of the first derivative of pressure normalized by LVDP (+dP/dt/LVDP and -dP/dt/LVDP, respectively) were derived from the pressure tracing.

Aequorin Loading and Normalization of Light Signals
Aequorin was macroinjected, and the heart was positioned in an organ bath as described previously.¹⁵ Aequorin light signals were measured with a photomultiplier¹⁵ and digitized and stored as described for LV pressure. The light signals were analyzed for peak systolic (L_sys) and end-diastolic (L_dias) light. To reduce the signal-to-noise ratio, 10 to 100 cycles were wave averaged at the time of interest when function was stable (<5% difference of LVDP) and pacing was possible. Because the magnitude of the aequorin light signal depends on the amount of aequorin that had entered the cell during the loading procedure, the light signal must be normalized according to the following technique: HOE642 does not alter intracellular Ca²⁺ transients under normoxic conditions (see Results). Therefore, the preischemic amplitude of the Ca²⁺ light transients (L) was chosen as a normalization reference. Because aequorin is consumed throughout the experiment, light values cannot simply be related to preischemic values as 100%, and aequorin consumption must be taken into account. For the conversion of light to calcium concentration, the method of fractional luminescence is used as described previously¹⁵ :

(1)

where the K_r value is 4.65 · 10⁶ mol/L and the K_tr value is 135. L_max(t) is the maximum light value when all aequorin would be simultaneously be activated by Ca²⁺ at time t.

Time dependency of L_max(t) due to aequorin consumption can be calculated as the following¹⁵ :

(2)

where the K_c value is 1.5 s^-1; aequorin consumption at 37°C was measured according to Kihara et al¹⁵ ; L_max(t=end) equals L_max at the end of the experiment; and

which is the time integral of aequorin light signal from time of interest (t) to the end of the experiment (t_end).

With the use of preischemic control values of 0.68 µmol/L for [Ca²⁺]_sys and of 0.31 µmol/L for [Ca²⁺]_dias, as previously reported, and with replacement of these values in equation 1, respectively, the following can be calculated¹⁵ :

With equations 1 and 2 and a [Ca²⁺]_sys value of 0.68 µmol/L, the following can be calculated:

(3)

Thus, L_pre was used in combination with the aequorin light integral from time t to the end of the experiment to calculate L_max(t=end). With L_max(t=end), aequorin light values can be converted into [Ca²⁺]_i at any other time point of the respective experiment with the use of equations 1, 2, and 3.

Analysis of Calcium Overload in the First Minute of Reperfusion
To analyze Ca²⁺ overload occurring in the first minute of reperfusion, the following parameters were used (Figure 2, bottom). [Ca²⁺]_isch was end-ischemic [Ca²⁺]_i; peak was the initial peak of Ca²⁺ signal in the first minute of reperfusion, reflecting the first Ca²⁺ influx; Oscill_max was the maximum of the first 10 transients of Ca²⁺ oscillations in the first minute of reperfusion, reflecting the amount of Ca²⁺ released from the overloaded sarcoplasmic reticulum during each oscillation on top of the cytosolic Ca²⁺ overload; I_(0–30) and I_(30–60) were the time integrals of the first or second 30 seconds of reperfusion, respectively, normalized by L_max(t), a global Ca²⁺ overload index; and I_(0–30)/I_(30–60) was the index of Ca²⁺ overload distribution with respect to time.

View larger version (23K): [in this window] [in a new window]   Figure 2. Original chart-strip recording of representative experiments without (A) or with (B) HOE642 treatment. On onset of ischemia, LVDP rapidly decays to zero. Subsequently, ischemic contracture develops. Hearts fibrillate on reperfusion. At 20 to 30 minutes after spontaneous defibrillation, mechanical function stabilizes. Ischemic Ca2+ overload was blunted with HOE642 treatment. At end of reperfusion, Ca2+ transients return to preischemic level. Bottom, First 40 seconds of reperfusion are displayed to characterize reperfusion-induced Ca2+ overload phenomenon (scale enlarged from top). LV pressure increases in parallel with [Ca2+]i, followed by Ca2+ oscillations. [Ca2+]isch, peak, and Oscillmax are Ca2+ overload indices as described in Methods. Note that Ca2+ overload on reperfusion was blunted by HOE642, correlating with improved postischemic recovery of mechanical function.

The time intervals for I_(0–30) and I_(30–60) were chosen according to preliminary experiments, demonstrating that the major part of the peak of the reperfusion-induced Ca²⁺ overload is over within 1 minute and that no significant differences could be detected for light integral measurements of 1 minute.

Measurement of pH_i With ³¹P NMR Spectroscopy
For NMR measurements, hearts were perfused in an NMR sample tube and inserted into the bore of a Bruker (AM 300) 7.05-T magnet (150 mm; Oxford Instruments) as previously described.^{16 31}P NMR spectra were collected at 121.5 MHz during 30-second intervals by signal-averaging 16 free induction decays with a pulse angle of 45° (recycle time 1.93 seconds). The free induction decays were analyzed in time domain (AMARES fit routine),¹⁷ and the inorganic phosphate (Pi) and phosphocreatine (PCr) resonance areas were analyzed (MRUI package). The chemical shift difference between Pi and PCr was used to obtain pH values from a standard curve.¹⁸

Experimental Protocol (Aequorin Experiments)
After the aequorin loading procedure, the temperature was increased to 37°C within 10 minutes, and the hearts were paced at 5 Hz. After steady state conditions were reached, a pressure-volume relationship was obtained to determine the volume at peak developed pressure (Vol_max) as previously described.¹³ LV volume was set to 50% of Vol_max and kept constant for the remainder of the experiment. After stabilization of mechanical function and aequorin light signals, HOE642 was added into the perfusate in the treated group, resulting in a concentration of 1 µmol/L. Vehicle (0.9% NaCl solution) was added to the perfusate in the untreated group (n=10 per group). Fifteen minutes later, no-flow ischemia was initiated. Pacing was discontinued 5 minutes after the initiation of ischemia. Hearts were reperfused after 30 minutes of ischemia. In all hearts, transient ventricular fibrillation occurred. Pacing was reinitiated after stabilization of the cardiac rhythm 5 minutes after spontaneous defibrillation. The hearts were reperfused for 30 minutes after spontaneous defibrillation.

Experimental Protocol (NMR Experiments)
Additional groups of hearts were examined (6 untreated, 6 HOE642 treated) with the NMR spectrometer as described earlier to measure pH_i. No aequorin loading was performed in these hearts, but otherwise, hearts were subjected to the same protocol.

Statistical Analysis
Data are reported as mean±SEM. A paired t test or a repeated measures ANOVA for within-group comparisons was performed where appropriate. A value of P<0.05 indicates significant differences between treated and untreated groups.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Effects of HOE642 on Baseline Cardiac Performance
No significant changes in mechanical function, [Ca²⁺]_i, or pH_i were induced with HOE642 under preischemic (values not shown) conditions, and all preischemic parameters for untreated and HOE642 hearts were similar (Figures 1A to 1F, Table).

View larger version (25K): [in this window] [in a new window]   Figure 1. , Untreated hearts. •, HOE642-treated hearts. A, LVDP. B, LVEDP. C, Coronary perfusion pressure (cPP). D, pHi in 5-minute time resolution. E, Amplitude of the Ca2+ transients [L/Lmax(t)] during paced cycles. F, Diastolic light (resting) values [Ldias/Lmax(t)] normalized by Lmax(t). Values are mean±SEM. Ischemia was started at t=0 minutes. *P<0.05 compared with untreated hearts.

View this table: [in this window] [in a new window]   Table 1. Time Course Parameter of Mechanical Function

Cardiac Function During Ischemia and Reperfusion
After the beginning of no-flow ischemia, LVDP declined to zero within <5 minutes (Figures 1A and 2). Ischemic contracture developed after 5 minutes up to 32 mm Hg (Figures 1B and 2). In the second half of the ischemic period, resting pressure declined slightly to 24 mm Hg at the end of the ischemic period (Figure 1B). No differences in mechanical function or resting pressure, respectively, could be detected up to this time point between HOE642-treated and untreated hearts. On reperfusion, LVEDP increased to 60±4.3 mm Hg in untreated hearts compared with 47±2.8 mm Hg in the treated hearts (P<0.05). All hearts showed low-amplitude contractions before going into ventricular fibrillation within 2 minutes (Figure 2). Time of ventricular fibrillation was not abbreviated with HOE642 treatment. After an average of 9±2 minutes, hearts spontaneously defibrillated. In the next 20 minutes of reperfusion, LVEDP slowly declined and LVDP increased, reaching a stable plateau 20 to 30 minutes after spontaneous defibrillation, resulting in an LVDP of 49.6±7.7 in untreated and 92.5±3.2 (values are percent of preischemic values) in treated hearts, respectively (P<0.05; Figure 1A). Similarly, at the end of reperfusion, LVEDP was 43±6.8 mm Hg in untreated hearts compared with 15±3.1 mm Hg in the HOE642 group (P<0.05; Figure 1B). Coronary perfusion pressure was not influenced by HOE642 treatment throughout the protocol (Figure 1C).

After reperfusion, TP was prolonged and +dP/dt/LVDP was decreased compared with preischemic values. Relaxation was impaired after reperfusion as indicated by an increase of tau and decrease in -dP/dt/LVDP. These abnormalities could be completely prevented with HOE642 treatment (Table).

The reported LV pressure results were taken from aequorin experiments. Measurements in NMR experiments showed similar results.

Intracellular Ca²⁺ During Ischemia and Reperfusion
In the first few minutes of ischemia, the amplitude of the Ca²⁺ transient increased by 30% in both groups and fell to zero after pacing was terminated (Figures 1E and 2). During ischemia, intracellular resting Ca²⁺ increased, as indicated by an increase in the aequorin light signal normalized by L_max(t) (Figures 1F and 2). HOE642 treatment significantly blunted the ischemic Ca²⁺ overload. On reperfusion, intracellular Ca²⁺ markedly increased, reaching its peak after 15 to 20 seconds, in parallel to an increase in LV resting pressure (Figure 2, bottom). Subsequently, pressure and [Ca²⁺]_i then slowly decreased until the first Ca²⁺ oscillations occurred (Figure 2). LV pressure showed only minor responses to Ca²⁺, indicating that the myofilaments were still desensitized at this early stage of reperfusion.

Ca²⁺ overload at end ischemia and on reperfusion was significantly attenuated by HOE642 pretreatment, as indicated by a reduced end-ischemic [Ca²⁺]_i, reduced peak, and reduced I_(0–30) and I_(30–60) values (Figure 3). Ca²⁺ overload not only was attenuated by HOE642 but also was delayed, as indicated by a reduced I_(0–30)/I_(30–60) ratio in treated (0.78±0.09) versus untreated (1.84±0.3, P<0.05) hearts. Within 5 minutes on reperfusion, [Ca²⁺]_i declined to preischemic values (Figure 2) with no differences between the groups after the first minute.

View larger version (24K): [in this window] [in a new window]   Figure 3. Ca2+ overload indices of reperfusion as defined in Method section and legend to Figure 2, bottom. *P<0.05 vs untreated (n=10 per group).

Peak systolic and LV end-diastolic [Ca²⁺]_i in untreated and HOE642-treated hearts were similar in both groups 30 minutes after reperfusion. There were no differences from preischemic values (Figure 1E), suggesting that the availability of Ca²⁺ to activate the myofilaments was not responsible for postischemic dysfunction.

pH_i on Reperfusion
Preischemic pH_i was similar for both groups. During ischemia, pH_i declined at a similar rate and extent, by 1.2 pH units, in both groups (Figure 1D). On reperfusion, pH_i was rapidly restored in the untreated group within 2 minutes (Figures 1D and 4). In the HOE642-treated group, recovery of pH_i was similar for the first 90 seconds of reperfusion. However, for the next 3 minutes of reperfusion, realkalinization was significantly delayed in HOE642-treated compared with untreated hearts. Later, pH_i reached preischemic values in both groups.

View larger version (21K): [in this window] [in a new window]   Figure 4. pHi at end ischemia and in first minutes of reperfusion (30-second time resolution, reperfusion at t=30 minutes). At end ischemia and first 90 seconds of reperfusion, acidosis was similar in both groups. In next 3 minutes, realkalinization was delayed with HOE642. *P<0.05 vs untreated (n=6 per group).

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
In the present study, we investigated the cardioprotective effects of HOE642, a cardioselective Na⁺/H⁺ exchange inhibitor, during ischemia-reperfusion injury. To our knowledge, this is the first report on [Ca²⁺]_i and pH_i measurements of the effects of a Na⁺/H⁺ exchange inhibitor with a temporal resolution of 30 seconds, the resolution required to evaluate fast changes of proton and Ca²⁺ homeostasis on reperfusion.

During ischemia, acidosis develops due to ATP breakdown and lactate production.^{3 19} The low pH_i stimulates pH regulating transport systems such as the Na⁺/H⁺ exchanger. After no-flow ischemia, extracellular pH drops secondary to intracellular acidification, thus likely reducing the activity of the Na⁺/H⁺ exchanger.³ On reperfusion, extracellular pH is immediately restored with a rapid increase in extracellular pH, and the Na⁺/H⁺ exchanger is reactivated.²⁰ The Na⁺/H⁺ exchanger then contributes to transient Na⁺ overload linked to Ca²⁺ overload via the Na⁺/Ca²⁺ exchanger working in reverse mode (Na⁺ out, Ca²⁺ in).²⁰ Events during the first few minutes of reperfusion are considered to be the main determinants of reperfusion injury.¹² One of the major factors for reperfusion injury leading to stunning, necrosis, and arrhythmias is the Ca²⁺ overload phenomenon.² Intracellular acidosis during the early phase of reperfusion can protect the myofilaments against reperfusion injury.^{3 12}

Ca²⁺ Overload and pH_i on Reperfusion
In the present study, the Ca²⁺ overload phenomenon was characterized in an isolated heart model with a temporal resolution of a few milliseconds. This resolution was sufficient to detect not only a global increase in [Ca²⁺]_i on reperfusion, as found with NMR indicator techniques^{5 7} or radioactive calcium,²¹ but also rapid sequences of Ca²⁺ transients as demonstrated in Figure 2 (bottom). This phenomenon is known as "Ca²⁺ oscillation," characteristic of Ca²⁺ overload.²² In addition, pH_i was measured with a time resolution of 30 seconds.

To analyze the effects of HOE642 on reperfusion-induced Ca²⁺ overload, various indices were defined as described in Methods and in Figure 2. In the present report, all Ca²⁺ overload indices were depressed with HOE642 treatment, although differences for Oscill_max were not significant (Figure 3). Furthermore, Ca²⁺ overload on reperfusion was delayed by HOE642, as indicated by a reduced I_(0–30)/I_(30–60) ratio. Although the reduction in Ca²⁺ overload with HOE642 was evident only during the first minute of reperfusion, [Ca²⁺]_i was still elevated for the next 4 minutes. The rise in pH_i makes the myofilaments most sensitive to injury after the first minute of reperfusion. Realkalinization was delayed from the second to the fourth minute of reperfusion by HOE642 (Figures 1D and 4). Therefore, both the effects on [Ca²⁺]_i and on pH_i are cardioprotective and may explain the markedly beneficial effect on postischemic recovery of systolic and diastolic functions (Figures 1A, 1B, and 2, Table).^{3 12}

In cardiomyocytes, the Na⁺/H⁺ exchanger is only 1 of several pH-regulating systems³ : protons can leave the cell via the lactate/H⁺ symporter if lactate is present and via the Na⁺/HCO₃^- symporter depending on the Na⁺ gradient across the cell membrane.³ The relative importance of these mechanisms is unknown. In the concentration used for the present study, HOE642 (1 µmol/L) inhibits >95% of Na⁺/H⁺ exchanger subtype I, the predominant subtype in cardiac tissue.^{4 10} Na⁺/H⁺ exchange is immediately activated on reperfusion by a reestablished pH gradient. Therefore, its inhibition can explain the observed reduction in Ca²⁺ influx (Figure 3). Because pH_i was found to be similar in both groups during the first 90 seconds of reperfusion (Figure 4), the expected effect of HOE642 on pH_i during this period was overridden by alternative mechanisms other than Na⁺/H⁺ exchange, presumably by lactate/H⁺ washout. Subsequently, inhibition of Na⁺/H⁺ exchange predominates as indicated by the differences in pH_i 2 to 5 minutes after reperfusion (Figure 4).

The observation that Na⁺/H⁺ exchange inhibition improves postischemic mechanical function is consistent with results from other groups who used in vivo or in vitro models of cardiac ischemia in various species.^{6 10 23} A decrease in Na⁺ and Ca²⁺ overload was demonstrated during 20 minutes of ischemia with NMR spectroscopy⁷ or ⁴⁵Ca²⁺ using the non-specific Na⁺/H⁺ exchange inhibitor amiloride in isolated hearts.⁵ Pretreatment with HOE694, a selective, but less potent, Na⁺/H⁺ exchange inhibitor compared with HOE642, improved cardiac output in the isolated working heart after 20 minutes of global ischemia.⁹ In blood-perfused isolated rabbit hearts subjected to 45 minutes of ischemia and 60 minutes of reperfusion, HOE694 improved postischemic recovery of systolic and diastolic function. High-energy phosphates and pH_i measured with ³¹P NMR spectroscopy were similar during ischemia. ATP and PCr depletion were attenuated by HOE694 after 60 minutes of reperfusion. pH_i showed a transient overalkalinization in untreated hearts 5 minutes after the beginning of reperfusion (time resolution 5 minutes), an effect abolished with HOE694.⁸

In contrast to our findings, ischemic contracture was reported to be attenuated by a Na⁺/H⁺ exchange inhibitor, and the incidence of reperfusion-induced arrhythmias was reduced.^{9 10 24} However, either these experiments were performed with regional ischemia in vivo or in vitro, or the duration of global no-flow ischemia was markedly shorter than that in our experiments. It is conceivable that the effects of Na⁺/H⁺ exchange inhibition on ischemic contracture or reperfusion-induced arrhythmias exist for only a lesser degree of ischemic damage. In accordance with the present report, selective inhibition of Na⁺/H⁺ exchange did not attenuate ischemic contracture during 40 minutes of no-flow ischemia in isolated buffer-perfused rat hearts²⁵ or in blood-perfused rabbit hearts.⁸

Although there were significant differences for [Ca²⁺]_i during ischemia, ischemic contracture was virtually identical in both groups (Figures 1B and 1F). This observation is in accordance with the view that during ischemia, the myofilaments are desensitized by acidosis and accumulation of Pi.²⁶ Ischemic contracture is presumably caused solely by rigor bond formation after a decrease in free energy (G).²⁶ However, in contrast to Ca²⁺ overload, ischemic energy metabolism was found to be unaltered by Na⁺/H⁺ exchange inhibition.⁸

The reduced accumulation of [Ca²⁺]_i during ischemia is likely to render the myocytes less prone to further Ca²⁺ overload on reperfusion. This finding is consistent with previous reports that provide evidence that Na⁺/H⁺ exchange inhibitors are more effective when given before ischemia rather than at the time of reperfusion.^{27 28}

Study Limitations
The changes in pH_i and [Ca²⁺]_i are independent observations, possibly but not necessarily related. According to current consensus,^{3 4 8} improved susceptibility to ischemia is most likely linked to the observed changes in pH_i and [Ca²⁺]_i, but no direct proof for this interrelation was given by the present data.

The aequorin light signal depends not only on [Ca²⁺]_i but also on pH_i, in the sense that both ions compete for Ca²⁺-binding sites of the aequorin molecule.²⁹ However, because pH_i was comparable in both groups during ischemia and during the first minute of reperfusion, [Ca²⁺]_i values quantified with the use of fractional luminescence were underestimated, but the relative differences between the treated and untreated hearts were unaffected.

Clinical Potential
In view of the experimental data, it is conceivable that HOE642 may become a clinically useful form of treatment in situations in which ischemia and reperfusion occur, such as cardioplegia during cardiac surgery, acute coronary syndrome, or before acute revascularization with angioplasty, bypass surgery, or thrombolysis. Patients with diagnosed coronary artery disease who are at risk for further ischemic events might be candidates for long-term treatment with HOE642. The preliminary results of a first clinical trial (Guardian Trial), revealing the beneficial effects of HOE642 in patients undergoing high-risk revascularization and preventing Q wave infarcts in patients with acute coronary syndrome, were promising.¹¹

	Acknowledgments

 
This work was supported in part by a grant from HMR Deutschland GmbH (Frankfurt/Main, Germany), grant SFB 355 A3 from the Deutsche Forschungsgemeinschaft, Germany (Drs Horn and Neubauer) and a grant from Verum-Foundation for behavior and environment (Dr Strömer).

Received September 9, 1999; revision received December 30, 1999; accepted January 4, 2000.

	References

Top Abstract Introduction Methods Results Discussion References

 
1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146–1149.[Abstract/Free Full Text]

2. Kusuoka H, Porterfield JK, Weisman HF, et al. Pathophysiology and pathogenesis of stunned myocardium: depressed Ca²⁺-activation as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest. 1987;79:950–961.

3. Piper HM, Balser C, Ladilov YV, et al. The role of Na⁺/H⁺-exchange in ischemia-reperfusion. Basic Res Cardiol. 1996;91:191–202.[Medline] [Order article via Infotrieve]

4. Scholz W, Albus U. Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy. Cardiovasc Res. 1995;29:184–188.[Medline] [Order article via Infotrieve]

5. Tani M, Neely JR. Role of intracellular Na⁺ in Ca²⁺ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts: possible involvement of H⁺-Na⁺ and Na⁺-Ca²⁺ exchange. Circ Res. 1989;65:1045–1056.[Abstract/Free Full Text]

6. Kennedy RH, Berlin JR, Ng YC, et al. Amiloride: effect on myocardial force of contraction, sodium pump and Na/Ca exchange. J Mol Cell Cardiol. 1986;18:177–188.[Medline] [Order article via Infotrieve]

7. Murphy E, Perlman M, London RE, et al. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res. 1991;68:1250–1258.[Abstract/Free Full Text]

8. Hendrikx M, Mubagwa K, Verdonck F, et al. New Na⁺-H⁺ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca²⁺ overload in isolated perfused rabbit heart. Circulation. 1994;89:2787–2798.[Abstract/Free Full Text]

9. du Toit EF, Opie LH. Role for the Na⁺-H⁺ exchanger in reperfusion stunning in isolated perfused rat heart. J Cardiovasc Pharmacol. 1993;22:877–883.[Medline] [Order article via Infotrieve]

10. Scholz W, Albus U, Counillon L, et al. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995;29:260–268.[Medline] [Order article via Infotrieve]

11. Ferguson JJ. Meeting highlights of the 48th Scientific Sessions of the American College of Cardiology. Circulation. 1999;100:570–575.[Free Full Text]

12. Kitakaze M, Weisfeldt ML, Marban E. Acidosis during early reperfusion prevents myocardial stunning in perfused hearts. J Clin Invest. 1988;82:920–927.

13. Strömer H, Cittadini A, Szymanska G, et al. Validation of different methods to compare cardiac function in isolated hearts of varying sizes. Am J Physiol. 1997;272:H501–H510.[Abstract/Free Full Text]

14. Grossman W. Evaluation of systolic and diastolic function of the myocardium. In: Grossman W, Baim D, eds. Cardiac Catheterization, Angiography, and Intervention. Philadelphia, Pa: Lea & Febiger, 1991.

15. Kihara Y, Grossman W, Morgan JP. Direct measurement of changes in intracellular calcium transients during hypoxia, ischemia and reperfusion of the intact mammalian heart. Circ Res. 1989;65:1029–1044.[Abstract/Free Full Text]

16. Neubauer S, Horn M, Naumann A, et al. Impairment of energy metabolism in intact residual myocardium of rat hearts with chronic myocardial infarction. J Clin Invest. 1995;95:1092–1100.

17. Mierisova S, van den Boogaart A, Tkac I, et al. New approach for quantitation of short echo time in vivo 1 H MR spectra of brain using AMARES. NMR Biomed. 1998;11:32–39.[Medline] [Order article via Infotrieve]

18. Moon RB, Richards JH. Determination of intracellular pH by 31-P magnetic resonance. J Biol Chem. 1973;248:7276–7278.[Abstract/Free Full Text]

19. Dennis SC, Gevers W, Opie LH. Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol. 1991;23:1077–1086.[Medline] [Order article via Infotrieve]

20. van Emous JG, Schreur JHM, Ruigrok TJC, et al. Both Na⁺-K⁺-ATPase and Na⁺-H⁺ exchanger are immediately active upon post-ischemic reperfusion in isolated rat hearts. J Mol Cell Cardiol. 1998;30:337–348.[Medline] [Order article via Infotrieve]

21. Allard MF, Flint JDA, English JC, et al. Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. J Mol Cell Cardiol. 1994;26:1551–1563.[Medline] [Order article via Infotrieve]

22. Ladilov YV, Siegmund B, Balser C, et al. Simulated ischemia increases the susceptibility of rat cardiomyocytes to hypercontracture. Circ Res. 1997;80:69–75.[Abstract/Free Full Text]

23. Ladilov YV, Siegmund B, Piper HM. Protection of reoxygenated cardiomyocytes against hypercontracture by inhibition of Na⁺/H⁺ exchange. Am J Physiol. 1995;37:H1531–H1539.

24. Aye NN, Xue YX, Hashimoto K. Antiarrhythmic effects of cariporide, a novel Na⁺/H⁺ exchange inhibitor, on reperfusion ventricular arrhythmias in rat hearts. Eur J Pharmacol. 1997;339:121–127.[Medline] [Order article via Infotrieve]

25. Shipolini AR, Yokoyama H, Galiñanes M, et al. Na⁺/H⁺ exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation. 1997;96:3617–3625.[Abstract/Free Full Text]

26. Koretsune Y, Marban E. Mechanism of ischemic contracture in ferret hearts: relative role of [Ca²⁺]_i elevation and ATP-depletion. Am J Physiol. 1990;258:H9–H16.[Abstract/Free Full Text]

27. Klein HH, Pich S, Bohle RM, et al. Myocardial protection by Na⁺-H⁺ exchange inhibition in ischemic, reperfused porcine hearts. Circulation.. 1995;92:912–917.[Abstract/Free Full Text]

28. Shimada Y, Hearse DJ, Avkiran M. Impact of extracellular buffer composition on cardioprotective efficacy of Na⁺/H⁺ exchanger inhibitors. Am J Physiol. 1996;270:H692–H700.[Abstract/Free Full Text]

29. Allan DG, Orchard CH. The effects of changes on pH on intracellular calcium transients in mammalian cardiac muscle. J Physiol. 1983;335:555–568.[Abstract/Free Full Text]

This article has been cited by other articles:

				P. J. Leary, S. Rajasekaran, R. R. Morrison, E. I. Tuomanen, T. K. Chin, and P. A. Hofmann A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2775 - H2784. [Abstract] [Full Text] [PDF]

				E. Murphy and C. Steenbergen Ion Transport and Energetics During Cell Death and Protection Physiology, April 1, 2008; 23(2): 115 - 123. [Abstract] [Full Text] [PDF]

				S. Javadov, A. Choi, V. Rajapurohitam, A. Zeidan, A. G. Basnakian, and M. Karmazyn NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition Cardiovasc Res, January 15, 2008; 77(2): 416 - 424. [Abstract] [Full Text] [PDF]

				T. Toda, T. Kadono, M. Hoshiai, Y. Eguchi, S. Nakazawa, H. Nakazawa, N. Higashijima, and H. Ishida Na+/H+ exchanger inhibitor cariporide attenuates the mitochondrial Ca2+ overload and PTP opening Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3517 - H3523. [Abstract] [Full Text] [PDF]

				T. Miura, T. Yano, K. Naitoh, M. Nishihara, T. Miki, M. Tanno, and K. Shimamoto {delta}-Opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-{varepsilon}-mediated phosphorylation of connexin 43 Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1425 - H1431. [Abstract] [Full Text] [PDF]

				S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25. [Abstract] [Full Text] [PDF]

				J. D. Kolarova, I. M. Ayoub, and R. J. Gazmuri Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2904 - H2911. [Abstract] [Full Text] [PDF]

				E. Kevelaitis, A. A. Qureshi, C. Mouas, F. Marotte, S. Kevelaitiene, M. Avkiran, and P. Menasche Na+/H+ exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 111 - 116. [Abstract] [Full Text] [PDF]

				M. Ten Hove, M. G. J. Nederhoff, and C. J. A. Van Echteld Relative contributions of Na+/H+ exchange and Na+/HCO3- cotransport to ischemic Nai+ overload in isolated rat hearts Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H287 - H292. [Abstract] [Full Text] [PDF]

				M. Spindler, K. Meyer, H. Stromer, A. Leupold, E. Boehm, H. Wagner, and S. Neubauer Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1039 - H1045. [Abstract] [Full Text] [PDF]

				M. Fujii, M. Avkiran, and D. J Chambers Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide Ann. Thorac. Surg., April 1, 2004; 77(4): 1398 - 1407. [Abstract] [Full Text] [PDF]

				R. M. Stevens, M. Salik Jahania, R. M. Mentzer Jr, and R. D. Lasley Sodium-hydrogen exchange inhibition attenuates in vivo porcine myocardial stunning Ann. Thorac. Surg., February 1, 2004; 77(2): 651 - 657. [Abstract] [Full Text] [PDF]

				Y. Teshima, M. Akao, S. P. Jones, and E. Marban Cariporide (HOE642), a Selective Na+-H+ Exchange Inhibitor, Inhibits the Mitochondrial Death Pathway Circulation, November 4, 2003; 108(18): 2275 - 2281. [Abstract] [Full Text] [PDF]

				H.E. Cingolani, I.L. Ennis, and S.M. Mosca NHE-1 and NHE-6 Activities: Ischemic and Reperfusion Injury Circ. Res., October 17, 2003; 93(8): 694 - 696. [Full Text] [PDF]

				Y. Wang, J. W. Meyer, M. Ashraf, and G. E. Shull Mice With a Null Mutation in the NHE1 Na+-H+ Exchanger Are Resistant to Cardiac Ischemia-Reperfusion Injury Circ. Res., October 17, 2003; 93(8): 776 - 782. [Abstract] [Full Text] [PDF]

				J. E. Davies, S. B. Digerness, S. P. Goldberg, C. R. Killingsworth, C. R. Katholi, P. S. Brookes, and W. L. Holman Intra-myocyte ion homeostasis during ischemia-reperfusion injury: effects of pharmacologic preconditioning and controlled reperfusion Ann. Thorac. Surg., October 1, 2003; 76(4): 1252 - 1258. [Abstract] [Full Text] [PDF]

				F. Callies, H. Stromer, R. H. G. Schwinger, B. Bolck, K. Hu, S. Frantz, A. Leupold, S. Beer, B. Allolio, and A. W. Bonz Administration of Testosterone Is Associated with a Reduced Susceptibility to Myocardial Ischemia Endocrinology, October 1, 2003; 144(10): 4478 - 4483. [Abstract] [Full Text] [PDF]

				M. Ruiz-Meana, D. Garcia-Dorado, P. Pina, J. Inserte, L. Agullo, and J. Soler-Soler Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H999 - H1006. [Abstract] [Full Text] [PDF]

				J. B. Ryan, M. Hicks, J. R. Cropper, S. R. Garlick, S. H. Kesteven, M. K. Wilson, M. P. Feneley, and P. S. Macdonald The initial rate of troponin I release post-reperfusion reflects the effectiveness of myocardial protection during cardiac allograft preservation Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 898 - 906. [Abstract] [Full Text] [PDF]

				S. B. Digerness, P. S. Brookes, S. P. Goldberg, C. R. Katholi, and W. L. Holman Modulation of mitochondrial adenosine triphosphate-sensitive potassium channels and sodium-hydrogen exchange provide additive protection from severe ischemia-reperfusion injury J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 863 - 871. [Abstract] [Full Text] [PDF]

				A. Rodriguez-Sinovas, D. Garcia-Dorado, F. Padilla, J. Inserte, J. A. Barrabes, M. Ruiz-Meana, L. Agullo, and J. Soler-Soler Pre-treatment with the Na+/H+ exchange inhibitor cariporide delays cell-to-cell electrical uncoupling during myocardial ischemia Cardiovasc Res, April 1, 2003; 58(1): 109 - 117. [Abstract] [Full Text] [PDF]

				D. M Bers, W. H Barry, and S. Despa Intracellular Na+ regulation in cardiac myocytes Cardiovasc Res, March 15, 2003; 57(4): 897 - 912. [Abstract] [Full Text] [PDF]

				D. G Allen and X.-H. Xiao Role of the cardiac Na+/H+ exchanger during ischemia and reperfusion Cardiovasc Res, March 15, 2003; 57(4): 934 - 941. [Abstract] [Full Text] [PDF]

				S. Muraki, C. D. Morris, J. M. Budde, Z.-Q. Zhao, R. A. Guyton, and J. Vinten-Johansen Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 155 - 164. [Abstract] [Full Text] [PDF]

				F. Brunner, R. Maier, P. Andrew, G. Wolkart, R. Zechner, and B. Mayer Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase Cardiovasc Res, January 1, 2003; 57(1): 55 - 62. [Abstract] [Full Text] [PDF]

				S. Engelhardt, L. Hein, U. Keller, K. Klambt, and M. J. Lohse Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in {beta}1-Adrenergic Receptor Transgenic Mice Circ. Res., April 19, 2002; 90(7): 814 - 819. [Abstract] [Full Text] [PDF]

				J. An, S. G. Varadarajan, A. Camara, Q. Chen, E. Novalija, G. J. Gross, and D. F. Stowe Blocking Na+/H+ exchange reduces [Na+]i and [Ca2+]i load after ischemia and improves function in intact hearts Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2398 - H2409. [Abstract] [Full Text] [PDF]

				J. D. Symons and S. Schaefer Na+/H+ exchange subtype 1 inhibition reduces endothelial dysfunction in vessels from stunned myocardium Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1575 - H1582. [Abstract] [Full Text] [PDF]

				Y. Toyoda, S. Khan, W. Chen, R. A. Parker, S. Levitsky, and J. D. McCully Effects of NHE-1 inhibition on cardioprotection and impact on protection by K/Mg cardioplegia Ann. Thorac. Surg., September 1, 2001; 72(3): 836 - 843. [Abstract] [Full Text] [PDF]

				M. Hendrikx, F. Rega, L. Jamaer, T. Valkenborgh, H. Gutermann, and U. Mees Na+/H+-exchange inhibition and aprotinin administration: promising tools for myocardial protection during minimally invasive CABG Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 633 - 639. [Abstract] [Full Text] [PDF]

				E. A. Aiello and H. E. Cingolani Angiotensin II stimulates cardiac L-type Ca2+ current by a Ca2+- and protein kinase C-dependent mechanism Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1528 - H1536. [Abstract] [Full Text] [PDF]

				G. T. Altemose, D. P. Zipes, J. Weksler, J. M. Miller, and J. E. Olgin Inhibition of the Na+/H+ Exchanger Delays the Development of Rapid Pacing-Induced Atrial Contractile Dysfunction Circulation, February 6, 2001; 103(5): 762 - 768. [Abstract] [Full Text] [PDF]

				W. E. Cascio, H. Yang, T. A. Johnson, B. J. Muller-Borer, and J. J. Lemasters Electrical Properties and Conduction in Reperfused Papillary Muscle Circ. Res., October 26, 2001; 89(9): 807 - 814. [Abstract] [Full Text] [PDF]

				S. Engelhardt, L. Hein, U. Keller, K. Klambt, and M. J. Lohse Inhibition of Na+-H+ Exchange Prevents Hypertrophy, Fibrosis, and Heart Failure in {beta}1-Adrenergic Receptor Transgenic Mice Circ. Res., April 19, 2002; 90(7): 814 - 819. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Strömer, H. Articles by Neubauer, S. Search for Related Content PubMed PubMed Citation Articles by Strömer, H. Articles by Neubauer, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL Medline Plus Health Information Cardiomyopathy Related Collections Cardiovascular Pharmacology Ischemic biology - basic studies